Ciencias de la Salud
Campo de conocimiento
Royal Prince Alfred Hospital
Sídney, AustraliaPublicaciones en colaboración con investigadoras/es de Royal Prince Alfred Hospital (9)
2024
-
Outcomes after surgical revascularization in diabetic patients
Interdisciplinary cardiovascular and thoracic surgery, Vol. 38, Núm. 2
-
Transatlantic analysis of patient profiles and mid-term survival after isolated coronary artery bypass grafting: a head-to-head comparison between the European DuraGraft Registry and the US STS Registry
Frontiers in Cardiovascular Medicine, Vol. 11
2023
-
Clinical outcomes and quality of life after contemporary isolated coronary bypass grafting: a prospective cohort study
International journal of surgery (London, England), Vol. 109, Núm. 4, pp. 707-715
2019
-
Prospective observational cohort study on grading the severity of postoperative complications in global surgery research
British Journal of Surgery, Vol. 106, Núm. 2, pp. e73-e80
2017
-
Use of failure-to-rescue to identify international variation in postoperative care in low-, middle- and high-income countries: A 7-day cohort study of elective surgery
British Journal of Anaesthesia, Vol. 119, Núm. 2, pp. 258-266
2016
-
Global patient outcomes after elective surgery: Prospective cohort study in 27 low-, middle- and high-income countries
British Journal of Anaesthesia, Vol. 117, Núm. 5, pp. 601-609
2015
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2009
-
Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results
Multiple Sclerosis, Vol. 15, Núm. 2, pp. 219-228